Create an account
Logo Aeromics


Address: ADRESA to be completed

Send an enquiry
Profile Image Aeromics

About Aeromics

Aeromics, Inc. is a clinical-stage pharmaceutical company developing an intravenously administered aquaporin-4 (AQP4) inhibitor (AER-271) for severe, acute ischemic stroke that will prevent or arrest brain swelling (cerebral edema) following an ischemic event.

By preventing brain swelling AER-271 will significantly improve survival following an ischemic brain event, lead to better outcomes and more complete and faster recovery and reduce the need for more invasive treatments such as decompressive craniectomy.

Aeromics is currently investigating the pharmacokinetics, safety and tolerability of AER-271 in a Phase 1 clinical trial.
Login And Write Your Review

Write Your Reviews

Writing great reviews may help others discover the places that are just apt for them. Here are a few tips to write a good review:

3 Star
Be the First One To Review This Listing!!!

Company Info

  • Year Founded
  • Number of Employees 50 - 99
  • Minimal Budget $10,000 - $25,000

Our Location

  • 11000 Cedar Ave #270, Cleveland , Ohio 44106 , United States

    View Map
Help & Support

What service do you need? DokaLink will help you

Add your business

#1 Business Directory and Service Provider

Find the Best Qualified B2B Service Providers for Your Business

© 2020 DokaLink All rights reserved.